Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
20m
Gilead And Merck Report Phase 2 Results For Islatravir And Lenacapavir Combination In HIV Treatment
Gilead Sciences Inc. (GILD) and Merck & Co Inc.(MRK) announced new results from a Phase 2 clinical study evaluating the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Advance to World Series
Reaches tentative union deal
Boat rider arrested in FL
Postpones US tour
Hurricane Oscar forms
Philip Zimbardo dies at 91
Frozen waffles recalled
Three Americans detained
PG&E shuts off power
Fire prompts evacuations
Antitrust ruling delayed
US deficit reaches $1.8T
School shooting report
Orionids meteor shower
Emergency abortion ruling
Calif. oil refinery closure
To furlough 700 workers
Bladder cancer drug pulled
At decade-high level
Probes near miss in Austin
2024 induction ceremony
Netanyahu's home targeted
Challenges military listing
G7 ministers back Ukraine
Ex-MN congressman dies
NYC Halloween dog parade
Nationwide blackout in Cuba
MS after game shooting
NC breaks turnout record
Republicans appeal ruling
NK sending troops to RU?
Opioid suits settlement deal
Related topics
Trodelvy
United States
NASDAQ
HIV
Eli Lilly and Company
Feedback